ask="N/A"
ask_size="N/A"
average_daily_volume="602695"
bid="N/A"
bid_size="N/A"
book_value="11.38"
change="+0.60"
change_from_200_day_moving_average="10.38"
change_from_50_day_moving_average="1.73"
change_from_52_week_high="-15.19"
change_From_52_week_low="30.45"
change_in_percent="+0.79%"
close="76.97"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-5.88"
ebitda="-230.87M"
eps_estimate_current_year="-6.14"
eps_estimate_next_quarter="-1.66"
eps_estimate_next_year="-6.66"
ex_dividend_date="N/A"
float_shares="37661000"
high="78.60"
high_52_weeks="92.16"
last_trade_date="1/6/2017"
last_trade_price="76.97"
last_trade_size="16009"
last_trade_time="4:00pm"
low="75.79"
low_52_weeks="46.52"
market_capitalization="3.14B"
moving_average_200_day="66.59"
moving_average_50_day="75.24"
name="Ultragenyx Pharmaceutical Inc."
notes="N/A"
one_year_target_price="93.67"
open="76.25"
pe_ratio="N/A"
peg_ratio="-0.42"
percent_change_from_200_day_moving_average="+15.59%"
percent_change_from_50_day_moving_average="+2.30%"
percent_change_from_52_week_high="-16.48%"
percent_change_from_52_week_low="+65.46%"
previous_close="76.37"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="6.71"
price_per_sales="24378.14"
revenue="128000.00"
shares_outstanding="40859000"
short_ratio="9.31"
stock_exchange="NMS"
symbol="RARE"
volume="408665"
weeks_range_52="46.52 - 92.16"
